Home › Neuroblastoma › Kentucky
Neuroblastoma clinical trials in Kentucky
5 studies for Neuroblastoma are looking for participants at sites in Kentucky.
Cities in Kentucky
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- University of Kentucky/Markey Cancer Center, Lexington
- Norton Children's Hospital, Louisville
RecruitingPhase 3
Up to age 30 · All sexes · Updated Oct 2, 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RecruitingPhase 2
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Sep 3, 2026 · NCT06541262Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- University of Kentucky/Markey Cancer Center, Lexington
RecruitingPhase 3
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville
RecruitingPhase 2
12 Months – 21 Years · All sexes · Updated Aug 12, 2026 · NCT05489887From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.